FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

12949011000001106: Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1842391000001117 Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1842401000001119 Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Is a Generic Atripla 600mg/200mg/245mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Is pack of Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) false Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has active ingredient Tenofovir disoproxil fumarate false Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has active ingredient Efavirenz false Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has active ingredient Emtricitabine false Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has AMP Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Efavirenz true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Tenofovir disoproxil fumarate true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start